Avantor Investor Conference Presentation Deck

M&A accelerates proprietary growth 88 APPROACH Expanded team of strategy and BD experts Evolving our method for target identification and diligence Robust pipeline augmented by connection to supplier and customer technologies $8B M&A capacity through 2025 Navantor™ FOCUS AREAS 1 2 Biopharma production Life science research Services 41st Annual J.P. Morgan Healthcare Conference 3 15

View entire presentation